Skip to Main Content

Paper Details

The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growth.
Neurooncol Adv
3
2023
ATRT, ATRT cell lines, ATRT cells, ATRT tumor, Atypical teratoid rhabdoid tumors, BT16, BT16 cell line, H2AX, MAF737, PARP, Poly (ADP-ribose), Poly (ADP-ribose) polymerases, Rucaparib, atypical teratoid rhabdoid tumor, cancer, luciferase, luciferase-expressing vector, mice, nude mice, patients, pediatric, pediatric brain tumors, tumor
Author NameAffiliation
Sujatha VenkataramanUniversity of Colorado Anschutz Medical Campus
Sujatha VenkataramanThe Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital
Rajeev VibhakarUniversity of Colorado Anschutz Medical Campus
Rajeev VibhakarThe Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital
Rajeev VibhakarCenter for Cancer and Blood Disorders, Children's Hospital
Rajeev VibhakarUniversity of Colorado Denver
  • 1 - 6

Datasets

Release 1.2